| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/12/1997 | WO1997020857A1 Cyclic dodecapeptide and process for the preparation thereof |
| 06/12/1997 | WO1997020856A1 ACYLATED ENOL DERIVATIVES OF α-KETOESTERS AND α-KETOAMIDES |
| 06/12/1997 | WO1997020854A1 Recombinant gas vesicles and uses thereof |
| 06/12/1997 | WO1997020580A1 Drug therapy |
| 06/12/1997 | WO1997020575A1 Targeted adenovirus vectors |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997020569A2 Bioartificial devices and cellular matrices therefor |
| 06/12/1997 | WO1997020564A1 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) |
| 06/12/1997 | WO1997020547A1 Endoparasiticidal agents |
| 06/12/1997 | WO1997020463A1 Controlled gene product delivery from a regulatable retroviral vector |
| 06/12/1997 | WO1997015655A3 New artificial tissue, method for the production and the use thereof |
| 06/12/1997 | WO1997012972A3 Regulated genes and uses thereof |
| 06/12/1997 | WO1997012963A3 A paf-acetylhydrolase and use in therapy |
| 06/12/1997 | WO1997012035A3 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 06/12/1997 | WO1997011169A3 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 06/12/1997 | DE19547529A1 New monoclonal antibody specific for membrane antigen on colon carcinoma |
| 06/12/1997 | DE19545472A1 Diagnosis of squamous epithelial cell carcinoma |
| 06/12/1997 | DE19545463A1 Organisch-chemische Verbindung und Verfahren zu ihrer Herstellung Organic chemical compound and processes for their preparation |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2404957A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2243508A1 Urogenital sinus derived growth factor nucleotide and amino acid sequences |
| 06/12/1997 | CA2239868A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239226A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2239203A1 Drug therapy |
| 06/12/1997 | CA2239196A1 Endoparasiticidal agents |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | CA2237181A1 Tissue factor - kunitz domain fusion proteins as factor viia inhibitors |
| 06/12/1997 | CA2236913A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/11/1997 | EP0778347A2 ATP and nucleic acid-binding protein with putative helicase and ATPase characteristics |
| 06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
| 06/11/1997 | EP0777748A1 Peptide librairies as a source of syngenes |
| 06/11/1997 | EP0777746A1 Assay for the detection of proteases |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777738A1 Condii toxoplasma p30 expression cassette |
| 06/11/1997 | EP0777736A1 Functional modified hsv1-tk |
| 06/11/1997 | EP0777733A1 Method of treating birds with avian myelomonocytic growth factor |
| 06/11/1997 | EP0777732A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 06/11/1997 | EP0777731A1 Cloning and regulation of an endothelial cell protein c/activated protein c receptor |
| 06/11/1997 | EP0777729A1 5-lipoxygenase-activating protein ii |
| 06/11/1997 | EP0777690A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| 06/11/1997 | EP0777689A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 06/11/1997 | EP0777688A1 New immunocontraceptive peptides |
| 06/11/1997 | EP0777687A1 Trefoil peptide dimer |
| 06/11/1997 | EP0777686A1 Trophic factors for central nervous system regeneration |
| 06/11/1997 | EP0777685A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777683A1 Antiprotozoal cyclic tetrapeptides |
| 06/11/1997 | EP0777682A1 New opioid peptide antagonists |
| 06/11/1997 | EP0777681A2 Cyclic cs-1 peptidomimetics, compositions and methods of using the same |
| 06/11/1997 | EP0777680A1 Urokinase receptor ligands |
| 06/11/1997 | EP0777677A1 Methods of identifying compounds useful for treating autoimmune diseases |
| 06/11/1997 | EP0777499A1 Live vaccine for the treatment of tumour diseases |
| 06/11/1997 | EP0777497A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 06/11/1997 | EP0777496A1 Topical anti-inflammatory composition and method |
| 06/11/1997 | EP0777495A1 Stable, aqueous alfa interferon solution formulations |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777491A1 Use of tasteless, hydrolysed collagen and agent containing the same |
| 06/11/1997 | EP0777490A1 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 06/11/1997 | EP0777489A1 Low molecular yeast active substance extract and process for preparing the same |
| 06/11/1997 | EP0777488A1 Composition and method for allogeneic mononuclear cell immunotherapy |
| 06/11/1997 | EP0777487A1 Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction |
| 06/11/1997 | EP0777485A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 06/11/1997 | EP0777482A1 Combined preparation for the therapy of immune diseases |
| 06/11/1997 | EP0777478A1 Inhibitors of rotamase enzyme activity |
| 06/11/1997 | EP0777474A1 Methods for the treatment of inflammatory joint disease |
| 06/11/1997 | EP0777458A1 Control of hair growth |
| 06/11/1997 | EP0723442A4 Lactone compounds for treating patients with precancerous lesions |
| 06/11/1997 | EP0656786A4 Health supplements containing phyto-oestrogens, analogues or metabolites thereof. |
| 06/11/1997 | EP0633763B1 Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use |
| 06/11/1997 | EP0630234B1 Controlled release acth containing microspheres |
| 06/11/1997 | EP0607186B1 Macrophage activating factor from animal vitamin d-binding protein |
| 06/11/1997 | EP0525005B1 Method for inhibiting cell growth and compositions useful therefor |
| 06/11/1997 | EP0472706B1 Induction of protection against viral infection |
| 06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
| 06/11/1997 | EP0394409B1 Macrophage-derived inflammatory mediator (mip-2) |
| 06/11/1997 | CN1151760A Serum paraoxonase |
| 06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
| 06/11/1997 | CN1151701A Cascade-polymer complexes and method of producing the same |
| 06/11/1997 | CN1151700A Tri-, tetra-, penta- and polypeptides and their therapeutic use as an antidepressant agent |
| 06/11/1997 | CN1151406A Method for purifying thrombomodulin |
| 06/11/1997 | CN1151323A Accelerating agent of polypeptide medicine mucosa absorbent type |
| 06/11/1997 | CN1151322A Hemopoietic forebody cell protective agent |
| 06/10/1997 | US5637698 Fused multiple ring lactams |
| 06/10/1997 | US5637686 Tata-binding protein associated factor, nucleic acids |
| 06/10/1997 | US5637616 Method for treating diseases mediated by proteases |
| 06/10/1997 | US5637612 Mixture with dipeptidase inhibitor |
| 06/10/1997 | US5637602 Nervous system disorders; gastrointestinal disorders |
| 06/10/1997 | US5637599 Arginine mimic derivatives as enzyme inhibitors |
| 06/10/1997 | US5637577 Treatment of potozoal diseases |
| 06/10/1997 | US5637575 Orally administering liquid composition comprising water soluble sulfated cyclodextrin derivative and nontoxic carrier |
| 06/10/1997 | US5637568 Composition for the sustained and controlled release of medicamentous substances and a process for preparing the same |
| 06/10/1997 | US5637567 Method for modifying, diagnosing, and screening for IGF-I sensitive cell barrier properties |
| 06/10/1997 | US5637566 Administering less often than daily and not in sustained release form |
| 06/10/1997 | US5637565 Cocrystallization of different streptogramins |
| 06/10/1997 | US5637495 Plasmids for production of human growth hormone or polypeptide analog thereof, hosts containing the plasmids, products manufactured thereby, and related methods |
| 06/10/1997 | US5637493 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |